Acitretin and treatment of the oral leucoplakias. A model to have an active molecules release

Journal of the European Academy of Dermatology and Venereology

Volumn 14, Issue 6, 2000, Pages 473-478

  Gaeta, Gm ^a,c   Gombos, F ^a   Femiano, F ^a   Battista, C ^a   Minghetti, P ^b   Montanari, L ^b   Satriano, Ra ^a   Argenziano, G ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c NONE   (Italy)

Author keywords

Acitretin; Mucoadhesive tablet; Oral leucoplakia; Topical treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; ETRETIN; PLACEBO; TRIACYLGLYCEROL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG RESPONSE; DRUG SALIVA LEVEL; DRUG TISSUE LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LEUKOPLAKIA; MALE; MODEL; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SIDE EFFECT; TABLET; TRIACYLGLYCEROL BLOOD LEVEL; VOLUNTEER;

ACITRETIN; ADMINISTRATION, BUCCAL; ADMINISTRATION, TOPICAL; ADULT; AGED; BIOPSY, NEEDLE; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; KERATOLYTIC AGENTS; LEUKOPLAKIA; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; REFERENCE VALUES; SALIVA; TABLETS; TREATMENT OUTCOME;

EID: 0034427087     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2000.00155.x     Document Type: Article

References (17)

1. Oral leukoplakia and malignant transformation
2. Leukoplakia revisited. A clinicopathologic study of 3256 leukoplakias
3. Acitretin in the treatment of severe disorders of keratinization
4. Coexistence of palmoplantar lichen planus and lupus erythematosus with response to treatment using acitretin
5. Etretinate in the treatment of ulcerative lichen planus
6. Pharmacokinetics and drug interactions of etretinate and acitretin
7. Teratogenic risk with etretinate and acitretin treatment
8. In vivo percutaneous absorption of acitretin in the hairless guinea pig and in the rhesus monkey
9. Bioadhesive analysis of controlled-release systems
10. Determination of acitretin in the skin, in the suction blister, and in plasma of human volunteers after multiple oral dosing
11. Cyclosporin bioadhesive gel in the topical treatment of erosive lichen planus
12. A double-blind comparison of acitretin and etretinate in the treatment of Darier's disease
13. Treatment of lichen planus with acitretin
14. A double-blind, placebo-controlled trial of acitretin for the treatment of psoriasis
15. Buccoadhesive slow-release tablets of acitretin: Design and 'in vivo' evaluation
16. Double-blind clinical trial of 0.05% clobetasol propionate ointment in orabase in the treatment of patients with vesiculoerosive diseases
17. Studio clinico sull'efficacia del Clobetasolo in formulazione bioadesiva in alcune stomatopatie